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Summary
Objectives:  We  determined  the  effect  of  two-time  inﬂation  of  the  stent  balloon  on  stent
expansion  and  its  responsible  factor.
Methods:  Subjects  included  61  patients  with  de  novo  coronary  artery  lesions,  in  whom  12
sirolimus-eluting,  27  paclitaxel-eluting,  and  22  other  stents  were  deployed  twice  at  identi-
cal inﬂation  pressures  (11.3  ±  2.3  atm)  and  inﬂation  times  (5,  10,  20,  and  40  s).  After  the  ﬁrst
and second  deployments,  minimum  lumen  diameter  (MLD),  minimum  lumen  area  (MLA),  and
distensibility  index  (DI)  were  determined  using  intravascular  ultrasound.
Results: After  the  second  inﬂation,  MLA  was  signiﬁcantly  increased  (5  s:  12.9%,  10  s:  14.5%,  20  s:
9.4%, 40  s:  9.5%).  MLD  and  DI  were  also  signiﬁcantly  increased.  In  the  single  and  double  inﬂa-
tion groups,  DI  in  each  group  was  signiﬁcantly  correlated  with  inﬂation  time  (single:  r  =  0.409,
double: r  =  0.351).  DI  was  not  signiﬁcantly  different  between  double  5-s  and  single  10-s  inﬂa-
tions, between  double  10-s  and  single  20-s  inﬂations,  or  between  double  20-s  and  single  40-s
inﬂations. Additional  stent  balloon  inﬂation  by  higher  pressure  in  30%  and  another  balloon  in
18% of  the  patients  were  required.
Conclusions:  Two-time  stent  balloon  inﬂation  may  allow  better  stent  expansion  regardless  of
inﬂation time  and  two-time  inﬂ
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nder  expansion  of  coronary  stents  may  cause  restenosis  or
arly  and  late  stent  thrombosis  of  the  lesion  after  coronary
nterventions  [1—5]. In  an  intravascular  ultrasound  (IVUS)
tudy,  adequate  stent  patency  at  follow-up  has  been  related
o  minimum  lumen  area  (MLA)  after  stent  deployment  [6].
alf of Japanese College of Cardiology.
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2Two-time  stent  balloon  inﬂation  
Stent  expansion  may  be  related  to  inﬂation  pressure  of  the
stent  balloon.  Stone  and  colleagues  indicated  that  sirolimus-
eluting  stents  (SESs)  expand  more  as  inﬂation  pressure  is
raised  from  12  to  18  atm  [7].  It  is  reported  that  higher-
pressure  inﬂation  at  20  atm  with  a  0.5-mm  larger  short
balloon  provides  adequate  SES  expansion  [8].  The  subse-
quent  incidence  of  restenosis  can  be  reduced  through  use
of  a  focal  expanding  balloon  for  stent  optimization  [9].  In
addition  to  inﬂation  pressure,  the  relationship  between  bal-
loon  inﬂation  time  and  stent  expansion  has  been  studied.  An
experimental  in  vitro  study  using  plastic  vials  showed  that
an  inﬂation  time  of  30  s or  more  was  adequate  for  optimum
stent  deployment,  expansion,  and  apposition  [10]. In  human
data,  Asano  et  al.  indicated  that  a  larger  expansion  of  SES
can  be  obtained  by  60-s  inﬂation  at  14  atm  compared  to  10-
s  inﬂation  [11]. Kawasaki  et  al.  compared  the  expansion  of
SES  and  paclitaxel-eluting  stent  (PES)  between  20-s  and  60-
s  inﬂation  times  and  indicated  that  use  of  a  60-s  inﬂation
time  may  result  in  more  optimal  stent  expansion  [12]. How-
ever,  such  a  long  inﬂation  time  cannot  be  maintained  when
the  stent  is  deployed  in  hemodynamically  critical  lesions,  for
example,  in  non-protected  left  main  coronary  artery  disease
or  proximal  left  anterior  descending  lesion  close  to  the  left
main  coronary  artery.  If  multiple  short  inﬂations  can  provide
better  stent  expansion,  this  method  may  be  useful  for  per-
forming  percutaneous  coronary  intervention  (PCI)  for  such
critical  lesions.  If  the  two-time  stent  balloon  inﬂation  may
provide  adequate  stent  expansion,  another  post  dilatation
balloon  is  not  needed  in  some  cases  and  we  may  save  the
cost  of  coronary  intervention.
Materials and methods
Study  population
This  study  was  prospectively  performed,  but  the  selec-
tion  of  the  subjects  in  each  inﬂation  time  group  were  not
randomized.  Each  stent  balloon  inﬂation  time  was  chosen
by  the  operator  in  the  patient.  The  study  protocol  was
approved  by  our  institutional  review  board.  The  subjects
included  61  patients  (angina  pectoris,  44;  old  myocar-
dial  infarction,  17)  with  de  novo  coronary  artery  lesions
in  which  coronary  stents  were  placed  between  October
2007  and  October  2009  in  Hiroshima  Prefectural  Hospital
(Tables  1  and  2).  Patients  with  acute  coronary  syndrome,
chronic  total  occlusion,  hemodialysis,  and  severe  calciﬁed
lesions  were  excluded  from  this  study.  Forty-one  men  and
twenty  women  were  included,  and  the  mean  age  was  71  ±  9
years.  Stent-delivered  lesions  had  75—99%  stenosis,  and  the
lesions  were  in  the  right  coronary  artery  (RCA)  in  21  cases,
left  main  trunk  (LMT)  in  1  case,  left  anterior  descending
artery  (LAD)  in  19  cases,  and  left  circumﬂex  artery  (LCX)
in  20  cases.  Lesions  included  2  cases  of  type  A,  21  cases  of
type  B1,  34  cases  of  type  B2,  and  4  cases  of  type  C.  Written
informed  consent  was  obtained  from  all  patients  before  PCI
was  performed.Procedure
A  6-Fr  guiding  catheter  was  placed  in  the  coronary  artery
for  PCI  via  the  trans-radial  or  trans-femoral  sheath.  Heparin
o
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8000  units)  was  used  intravenously  before  the  PCI  pro-
edure.  After  a  0.014-in.  guide  wire  crossed  the  stenotic
esions,  the  lesions  in  all  cases  were  dilated  by  a  balloon
receding  stent  placement.  IVUS  was  used  to  determine
tent  size  and  length.  Stent  diameters  ranged  from  2.5  mm
o  4.0  mm  (mean:  3.06  ±  0.41  mm)  and  stent  length  ranged
rom  10  mm  to  33  mm  (mean:  19.2  ±  5.5  mm).  Among  the
1  patients,  the  implanted  stents  were  drug  eluting  in  41
ases  (12  SES,  27  PES,  2  zotarolimus-eluting  stents)  and  bare
etal  stents  (BMS)  in  20  cases.  The  stents  were  placed  in  the
esions  and  inﬂated  twice  in  all  cases  at  the  same  inﬂation
ressure  (mean:  11.3  ±  2.3  atm)  by  the  stent  delivery  bal-
oon  with  an  inﬂation  time  of  5  s (13  cases),  10  s  (18  cases),
0  s  (14  cases),  or  40  s  (16  cases).  After  the  ﬁrst  and  sec-
nd  inﬂations,  the  stent  lesions  were  examined  by  IVUS  and
inimal  stent  diameters  (MLD)  and  areas  (MLA)  were  noted.
hen  adequate  expansion  was  not  obtained  after  the  second
nﬂation,  additional  higher-pressure  inﬂation  was  performed
y  the  stent  balloon  or  another  balloon.
VUS  study
 2.9-Fr  IVUS  catheter  with  40  MHz  transducer  (Atlantis  Pro;
oston  Scientiﬁc,  Natick,  MA,  USA)  was  used  in  the  present
tudy.  The  IVUS  examination  was  performed  after  balloon
ilation  of  the  lesions,  ﬁrst  deployment  of  the  stent,  and
econd  inﬂation  with  the  same  stent  balloon  at  same  inﬂa-
ion  pressure.  The  IVUS  image  was  acquired  by  motorized
ullback  speed  at  0.5  mm/s  from  a  point  >10  mm  distal
o  >10  mm  proximal  through  the  stent  or  lesion.  Quantita-
ive  coronary  ultrasound  (QCU)  was  performed  in  all  lesions
sing  a  commercially  available  software  package  (Galaxy2;
oston  Scientiﬁc)  and  the  vessel  diameter,  MLD,  and  MLA
ere  determined.  Distensibility  index  (DI;  %)  was  deﬁned  as
ttained  MLA  over  the  predicted  stent  area  at  the  inﬂation
ressure.  The  predicted  stent  area  was  obtained  based  on
he  compliance  chart.
tatistics
he  changes  in  variables  between  the  ﬁrst  and  second  inﬂa-
ion  were  compared  by  the  Wilcoxon  test  (PASW  Statistics
8).  The  differences  in  DI  between  inﬂation  time  groups
ere  examined  by  the  Mann—Whitney  test.  The  correlation
etween  the  DI  and  inﬂation  time  was  examined  by  Spear-
an’s  rank  correlation  test.  A  p-value  <0.05  was  considered
tatistically  signiﬁcant.
esults
y  the  second  inﬂation,  MLD  signiﬁcantly  (p  <  0.005)
ncreased  from  2.32  ±  0.35  mm  to  2.47  ±  0.35  mm  (6.5%)  in
he  5-s  group,  from  2.20  ±  0.31  mm  to  2.36  ±  0.33  mm  (7.3%)
n  the  10-s  group,  from  2.24  ±  0.45  mm  to  2.34  ±  0.42  mm
4.5%)  in  the  20-s  group,  and  from  2.36  ±  0.42  mm  to
.47  ±  0.39  mm  (4.7%)  in  the  40-s  group  (Fig.  1).  By  the  sec-
nd  inﬂation,  MLA  was  also  signiﬁcantly  (p  <  0.005)  increased
rom  5.19  ±  1.44  mm2 to  5.86  ±  1.61  mm2 (12.9%)  in  the  5-
 group,  from  4.68  ±  1.18  mm2 to  5.36  ±  1.29  mm2 (14.5%)
n  the  10-s  group,  from  4.98  ±  1.67  mm2 to  5.43  ±  1.73  mm2
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Table  1  Patient  characteristics.
5-s  group  (n  =  13) 10-s  group  (n  =  18)  20-s  group  (n  =  14)  40-s  group  (n  =  16)  Total  (n  =  61)
Male/female  11/2  11/7  8/6  11/5  41/20
Age (years)  71  ±  7  67  ±  10  70  ±  9  75  ±  9  71  ±  9
Diabetes 3  8  7  6  24
Hypertension  10  15  13  11  49
Hyperlipidemia 8  13  11  13  45
Smoking 3 0 5 7  15
Hemodialysis 0 0 0 0 0
Table  2  Lesion  and  procedural  characteristics.
5-s  group
(n  =  13)
10-s  group
(n  =  18)
20-s  group
(n  =  14)
40-s  group
(n  =  16)
Total
(n  =  61)
Lesion
RCA/LMT/LAD/LCX  4/1/6/2  6/0/5/7  4/0/4/6  7/0/4/5  21/1/19/20
Type A/B1/B2/C  0/6/7/0  0/3/14/1  0/3/10/1  2/9/3/2  2/21/34/4
Stent
Diameter (mm) 3.23  ±  0.39 3.01  ±  0.41 2.96  ±  0.35  3.06  ±  0.47  3.06  ±  0.41
Length (mm) 18.2  ±  5.7 18.6  ±  5.3  17.7  ±  4.7  22.1  ±  5.7  19.2  ±  5.5
Pressure (atm) 10.4  ±  2.7 12.1  ±  2.0 12.1  ±  1.8  10.5  ±  2.2  11.3  ±  2.3
SES/PES/Others 1/5/7 6/10/2  3/5/6  2/7/7  12/27/22
Post-dilatation  balloon
Stent  balloon  alone/Another  balloon 6/3 5/2 6/4 1/2  18/11
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cRCA, right coronary artery; LMT, left main trunk; LAD, left anterio
stent; PES, paclitaxel-eluting stent.
9.4%)  in  the  20-s  group,  and  from  5.45  ±  1.78  mm2 to
.97  ±  1.84  mm2 (9.5%)  in  the  40-s  group  (Fig.  2).  The
xtent  of  expansion  of  the  MLD  and  MLA  did  not  have
igniﬁcant  difference  between  groups.  DI  was  signiﬁcantly
p  <  0.005)  greater  in  the  second  inﬂation  in  each  group  (5-s
roup:  59.6  ±  9.6%  vs.  67.0  ±  9.3%;  10-s  group:  59.7  ±  9.3%
I
n
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n
igure  1  Changes  in  minimal  lumen  diameter  (MLD)  by  two-time  in
ompared with  the  ﬁrst  inﬂation  in  every  inﬂation  time  group.cending artery; LCX, left circumﬂex artery; SES, sirolimus-eluting
s.  68.6  ±  9.9%;  20-s  group:  66.2  ±  10.3%  vs.  72.3  ±  10.7%;
0-s  group:  70.0  ±  11.9%  vs.  77.0  ±  12.2%)  (Fig.  3,  Table  3).
n  both  the  single  and  double  inﬂation  groups,  DI  was  sig-
iﬁcantly  correlated  with  inﬂation  time  (single:  r  =  0.409,
 <  0.002,  double:  r  =  0.351,  p  <  0.01)  (Fig.  4).  DI  was  not  sig-
iﬁcantly  different  between  double  5-s  inﬂation  and  single
ﬂation.  MLD  was  signiﬁcantly  increased  by  the  second  inﬂation
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Figure  2  Changes  in  minimum  lumen  area  (MLA)  by  two-time  inﬂation.  MLA  was  signiﬁcantly  increased  by  the  second  inﬂation
s
acompared with  the  ﬁrst  inﬂation  in  every  inﬂation  time  group.
10-s  inﬂation,  between  double  10-s  inﬂation  and  single  20-s
inﬂation,  and  between  double  20-s  and  single  40-s  inﬂation
(Fig.  5).
No  signiﬁcant  differences  in  the  increment  of  DI  by  the
second  inﬂation  were  observed  among  SES,  PES,  and  BMS
groups  (SES:  64.5  ±  11.1%  vs.  73.4  ±  12.1%;  PES:  64.5  ±  11.1%
vs.  73.4  ±  12.1%;  BMS:  61.5  ±  10.8%  vs.  68.7  ±  11.1%)
(p  <  0.05).
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Figure  3  Changes  in  distensibility  index  (DI)  by  two-time  inﬂation
ﬁrst inﬂation  in  every  inﬂation  time  group.An additional  higher-pressure  inﬂation  using  the  same
tent  balloon  was  needed  in  18  of  the  61  patients.  However,
nother  balloon  was  needed  in  only  11  of  the  61  patients.iscussion
dequate  stent  expansion  is  important  for  maintaining  good
linical  outcomes  after  coronary  stenting  in  patients  with
.  DI  was  signiﬁcantly  greater  in  the  second  inﬂation  than  the
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Table  3  Percentage  of  MLD,  MLA,  and  DI  increases.
5-s  group  (n  =  13)  10-s  group  (n  =  18)  20-s  group  (n  =  14)  40-s  group  (n  =  16)
MLD
Post  ﬁrst  inﬂation  (mm)  2.32  ±  0.35  2.20  ±  0.31  2.24  ±  0.45  2.36  ±  0.42
Post second  inﬂation  (mm)  2.47  ±  0.35  2.36  ±  0.33  2.34  ±  0.42  2.47  ±  0.39
Percentage of  increase  6.5%  7.3%  4.5%  4.7%
MLA
Post ﬁrst  inﬂation  (mm2)  5.19  ±  1.44  4.68  ±  1.18  4.98  ±  1.67  5.45  ±  1.78
Post second  inﬂation  (mm2)  5.86  ±  1.61  5.36  ±  1.29  5.43  ±  1.73  5.97  ±  1.84
Percentage of  increase 12.9%  14.5%  9.4%  9.5%
DI
Post ﬁrst  inﬂation  (%) 59.55  ±  9.62  59.72  ±  9.33  66.19  ±  10.31  70.02  ±  11.89
Post second  inﬂation  (%)  67.00  ±  9.33  68.62  ±  9.95  72.31  ±  10.69  77.03  ±  12.20
Percentage of  increase  12.5%  14.9%  9.2%  10.0%
MLD, minimum lumen diameter; MLA, minimum lumen area; DI, distensibility index.
Figure  4  Correlations  between  distensibility  index  (DI)  and  inﬂation  time  (Spearman’s  rank  correlation).  DI  signiﬁcantly  correlated
with inﬂation  time  in  the  both  single  and  double  inﬂation  groups  (single  inﬂation:  r  =  0.409,  double  inﬂation:  r  =  0.351).
Figure  5  Comparison  of  distensibility  index  (DI)  between  the  groups  of  same  total  inﬂation  time.  DI  in  each  group  was  not
signiﬁcantly  different  when  the  total  inﬂation  time  of  single  inﬂation  and  double  inﬂation  was  same.
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coronary  heart  disease.  IVUS  has  played  an  important  role
in  estimating  stent  expansion  when  coronary  stents  are
deployed  in  stenotic  lesions.  An  IVUS  study  by  Costa  et  al.
showed  that  compliance  charts  fail  to  predict  ﬁnal  MLD  and
MLA  [13,14].  IVUS  revealed  smaller  minimal  intra-stent  lumi-
nal  diameters  in  lower  dilation  pressures  as  compared  with
quantitative  coronary  angiography  (QCA)  [15]. The  optimal
thresholds  of  minimal  stent  area  to  predict  adequate  follow-
up  minimal  luminal  area  was  5  mm2 for  the  SES  and  6.5  mm2
for  the  BMS  [6].
There  have  been  several  studies  on  the  relationship
between  stent  expansion  and  inﬂation  pressure  of  stent  bal-
loon.  Stent  expansion  may  be  affected  by  both  stent  delivery
pressure  and  stent  structure.  Javaid  et  al.  described  that,
based  on  the  MUSIC  criteria,  stent  expansion  is  inadequate
in  80%  of  patients  with  SES  and  in  63%  of  patients  with
PES  at  14  atm  inﬂation  pressure  and  that  stent  expansion
improved  to  48%  in  SES  and  34%  in  PES  by  20  atm  inﬂa-
tion  pressure  [16]. Higher-pressure  inﬂation  at  20  atm  with
a  0.5  mm  larger  balloon  provided  adequate  SES  expansion
[8].  The  incidence  of  restenosis  was  signiﬁcantly  lower  in
the  high-pressure  inﬂation  group  (9%)  than  in  the  usual  pres-
sure  group  (22%)  [9].  Moreover,  under  expansion  of  the  stent
may  be  related  to  early  and  late  stent  thrombosis.  The  inci-
dence  of  angiographically  documented  stent  thrombosis  in
drug  eluting  stent  (DES)  was  1.3  per  100  person-years  in  a
European  study  [17]  and  0.54%  person-years  in  a  Japanese
multi-center  study  [18]. In  an  IVUS  study,  stent  malapposi-
tion  was  observed  in  73.9%  of  DES  patients  but  not  in  BMS
patients  [19]. More  precise  information  about  neointimal
growth  or  stent  mal-apposition  after  DES  implantation  was
gathered  by  optical  coherence  tomography  and  poor  intimal
coverage  was  indicated  even  in  the  patients  who  underwent
stent  placement  more  than  3  months  previously  [20—22].
Therefore,  adequate  stent  expansion  may  be  important  for
DES  implantation.
On  the  other  hand,  few  studies  have  examined  the  rela-
tionship  between  balloon  inﬂation  time  and  stent  expansion.
Trindade  et  al.  conducted  an  experimental  study  using
plastic  vials  with  a  3.5-mm  internal  diameter,  examining
stainless  steel  stent  expansion  with  balloon  inﬂation  time
from  5  to  60  s.  In  the  study,  inﬂation  time  of  30  s  or  more
was  adequate  for  optimum  stent  deployment,  expansion,
and  apposition  [10]. Asano  et  al.  compared  SES  expansion
in  patients  with  coronary  heart  disease  using  inﬂation  time
of  10  s  and  60  s at  14  atm  inﬂation  pressure,  and  larger  SES
expansion  was  obtained  by  60-s  inﬂation  as  compared  with
10  s  inﬂation  [11]. Kawasaki  et  al.  compared  SES  and  PES
expansion  at  20-s  and  60-s  inﬂation  times  at  20  atm  inﬂa-
tion  pressure  and  indicated  that  the  60-s  delivery  inﬂation
time  may  result  in  more  optimal  stent  expansion  [12]. How-
ever,  we  cannot  maintain  such  a  long  inﬂation  time  when  the
stent  is  deployed  in  non-protected  left  main  coronary  artery
disease,  proximal  left  anterior  descending  lesions  close  to
the  left  main  coronary  artery,  proximal  right  coronary  lesion
with  right  dominant  coronary  artery,  or  the  donor  artery
of  collateral  circulations  because  blood  pressure  may  drop
or  severe  bradycardia  may  occur  during  such  a  long  inﬂa-
tion.  If  multiple  short  inﬂations  provide  more  adequate  stent
expansion,  this  method  may  be  useful  in  PCI  for  such  criti-
cal  lesions.  Moreover,  if  better  expansion  can  be  attained  by
multiple  stent  inﬂations  with  a  stent  balloon  instead  of  using
B
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nother  high-pressure  balloon  after  stent  deployment,  the
CI  cost  will  be  also  lower.  Therefore,  we  examined  whether
dditional  stent  expansion  was  obtained  with  the  second
tent  balloon  inﬂation.
At  all  inﬂation  times  (5—40  s),  MLA  was  greater  by
.4—14.5%  after  the  second  stent  balloon  inﬂation.  MLD
nd  DI  were  also  signiﬁcantly  increased  after  the  second
tent  balloon  inﬂation.  These  better  expansions  by  the  sec-
nd  inﬂation  were  almost  the  same  in  every  kind  of  stent.
he  responsible  mechanism  of  the  better  stent  expansion
y  the  two-time  stent  balloon  inﬂation  is  not  known.  The
revious  studies  suggested  the  longer  the  inﬂation  time  the
ore  expansion  of  the  stents.  We  also  found  that  in  the
ingle  and  double  inﬂation  groups,  DI  in  each  group  was  sig-
iﬁcantly  correlated  with  inﬂation  time.  Moreover,  in  the
resent  study,  the  same  total  inﬂation  time  (double  5  s  vs.
ingle  10  s,  double  10  s  vs.  single  20  s  and  double  20  s vs.
ingle  40  s)  provided  similar  DI.  The  above  ﬁndings  sug-
est  that  two-time  balloon  inﬂation  may  be  equivalent  to
otal  longer  inﬂation  time  and  may  result  in  better  stent
xpansion.
We  sometimes  feel  the  resistance  when  we  pull  back  the
tent  delivery  balloon  after  deployment  of  the  stent.  The
bove  facts  may  mean  inadequate  stent  expansion  in  single
nﬂation  of  the  stent  balloon.  From  our  present  ﬁndings,  we
ecommend  routine  two-time  stent  balloon  inﬂation  at  stent
elivery.  Recently,  another  high  pressure  balloon  has  been
requently  used  after  deployment  of  the  stents  for  the  pur-
ose  of  preventing  mal-apposition  of  the  stents,  especially
n  DES.  In  the  present  study,  additional  higher-pressure  inﬂa-
ion  by  the  same  stent  balloon  was  required  in  30%  of  the
atients.  However,  another  high-pressure  balloon  or  a  differ-
nt  size  balloon  was  required  in  only  18%  of  the  61  patients.
hus,  two-time  stent  balloon  inﬂation  may  save  PCI  cost  by
ecreasing  the  number  of  PCI  balloons  used.
imitations
he  patient  selection  in  this  study  was  not  randomized.  The
esion  characteristics  of  the  patients  in  each  group  were  not
lways  identical.  Therefore,  selection  bias  may  exist  in  the
resent  results.  However,  better  stent  expansion  by  two-
ime  stent  balloon  inﬂation  at  about  11  atm  was  achieved
n  any  inﬂation  time  and  any  type  of  stent.  Therefore,  we
onclude  that  there  is  better  expansion  with  two-time  stent
alloon  inﬂation  for  stent  deployment.  In  the  present  study,
here  were  no  patients  with  severe  calciﬁed  lesions  neces-
ary  for  the  rotablator  technique.  If  the  patients  have  severe
alciﬁed  lesions,  two-time  inﬂation  may  not  always  have
etter  expansion.  It  is  still  unknown  whether  more  than  two
nﬂation  times  can  result  in  more  stent  expansion.  The  stent
esigns  or  materials  may  also  affect  the  stent  expansion.
hese  should  be  further  studied  in  the  future.
onclusionsetter  stent  expansion  can  be  achieved  with  two-time  stent
alloon  inﬂation  compared  with  single  inﬂation  regardless  of
he  inﬂation  time.  Total  longer  inﬂation  time  may  be  related
o  its  better  expansion.
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